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Abstract 
Background: Recent research has shown that betaine supplementation can increase 
strength and power performance. To further investigate the ergogenic effects of betaine 
supplementation a balanced, randomized, double-blind, repeated measures crossover 
study was designed to examine select hormonal and muscle signaling responses during 
supplementation.  
Methods: Twelve recreationally active men (age, 19.7 ± 1.23 years; height, 172.6 ± 5.61 
cm; weight, 84.27 ± 15.3 kg; body fat, 18.7 ± 7.0%; BMI, 28.2 ± 4.0) with a minimum of 
3 months of resistance training including back squat and bench press participated in the 
study. A within crossover design was utilized and subjects were randomly assigned to 
either betaine or placebo group. Subjects performed an acute exercise test (AET) 
consisting of maximal vertical jumps, isometric bench press, isometric squat, and a box 
lift test before and after 14 days of supplementation (twice a day) with either betaine 
(1.25 g dissolved in Gatorade) or placebo (same volume of Gatorade alone). During each 
AET, blood samples were obtained at pre, mid, post, +5, and +15 and were analyzed for 
GH, IGF-1 and cortisol. Also during each AET, muscle biopsies were obtained from the 
vastus lateralis at pre and +10 and were analyzed for select muscle signaling proteins 
(Total Akt, Akt S473, p70 S6k1, p70 S6k1 T389, and AMPK T172). Following a 14 day 
washout period, subjects crossed over to the other supplementation protocol and 
performed the same pre and post AETs.  
Results: Following betaine supplementation, there was a significant increase in isometric 
squat force production and number of boxes lifted during the box lift test. However, there 
were no significant differences in isometric bench press and vertical jumps between 
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supplementation groups. There was a significant increase in area under the curve (AUC) 
for GH and IGF-1 and a significant decrease (AUC) for cortisol following 14 days of 
betaine supplementation. Following betaine supplementation, there was an increased in 
muscle Total Akt. Phosphorylation of Akt at S473 and phosphorylation of p70 S6k at 
T389 were maintained following betaine supplementation while these values were 
decreased during placebo supplementation. Phosphorylation of AMPK at T172 was 
decreased following betaine and placebo supplementation.   
Conclusion: Betaine supplementation increased force production and muscular 
endurance. These performance measures correspond to increases in anabolic hormones 
(GH and IGF-1) and maintenance of anabolic muscle signaling (Total Akt, Akt and p70 
S6k phosphorylation) responses, as well as the decrease in catabolic hormone (cortisol) 
and inhibitory muscle signaling (AMPK phosphorylation) following 14 days of betaine 
supplementation 
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Chapter 1: Introduction 
 Skeletal muscle plasticity allows the body to adapt to a wide range of stimuli. On 
the two ends of the exercise spectrum, endurance training and resistance training provoke 
different adaptations in muscle. While endurance training focuses on improving work 
capacity and decreasing fatigue mainly via increased mitochondrial biogenesis, resistance 
training focuses on improving strength and power via increased protein accretion and 
neural recruitment. For resistance training, the acute program variables (exercise choice, 
exercise order, load, volume, and rest intervals) dictate the specific stimuli resulting in 
the specific muscle adaptations 
30
. 
 Resistance exercise creates an anabolic environment by mediating both hormonal 
and molecular signaling cascades. From a hormonal perspective, an acute bout of 
resistance exercise increases testosterone, growth hormones (GHs), and Insulin-Like 
Growth Factor 1 (IGF-1). Testosterone is a key signal to protein synthesis and works 
through the androgen receptor to regulate gene transcription. GH and IGF-1 bind to their 
respective receptors and signal through phosphatidylinositol 3-kinase (PI-3K) 
45
. PI-3K 
potentiates the anabolic signal to the mammalian target of rapamycin (mTOR), which is 
considered a key regulator of muscle signaling and protein synthesis. mTOR further 
signals downstream to the 70 kDa ribosomal protein S6 kinase (p70 S6k) and eukaryotic 
initiation factor 4E-binding protein 1 (4E-BP1) to initiate the translation of mRNA and 
protein synthesis 
20
. Although testosterone is considered a major promoter of muscle 
protein accretion 
50
, for the scope of this study, we will focus entirely on mTOR 
signaling. 
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On the contrary, endurance training stimulates a different pathway to exert its 
effect. Specifically, endurance training stimulates adenosine monophosphate-activated 
kinase (AMPK) / peroxisome-proliferator-activated receptor γ coactivator 1α (PGC-1α) 
pathway which stimulates mitochondrial biogenesis and other endurance training 
adaptations 
28
. Interestingly, the AMPK / PGC-1α pathway inhibits the mTOR pathway 
and decreases protein synthesis 
10
. Due to the specificity of training adaptations and the 
commonality of concurrent training (both resistance training and endurance training), the 
interaction of the mTOR and AMPK pathway has been of great interest.   
 As interest on the muscle signaling pathways has grown, more research has 
focused on the impact of nutrition and supplementation on these pathways. Indeed, 
nutritional interventions (most predominantly branch chain amino acids 
34
) have been 
shown to increase signaling and protein synthesis. Similarly, other supplements may 
exert their ergogenic effects through signaling pathways.  
 Recent studies have shown improvements in performance with betaine 
supplementation 
21, 31
, but have not shown the mechanism for this improvement. Some 
suggested that betaine supplementation may aid athletic performance due to its role as an 
osmolyte and a methyl donor to produce creatine 
11, 32
, but further research is necessary to 
show its true mechanism of action. 
 Therefore, the purpose of this study was to examine the effect of betaine 
supplementation on performance, and hormonal and muscle signaling responses in order 
to more effectively identify a mechanism of ergogenic action. We hypothesized that 
betaine supplementation would increase strength and power performance via increased 
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anabolic signaling hormonally, as well as potentiating the anabolic signal through the 
mTOR pathway.  
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Chapter 2: Review of Literature 
 For the purpose of this literature review, the muscle signaling pathway and 
betaine supplementation will be reviewed. To begin, muscle signaling will be reviewed in 
a broad scope. Then the AMPK / PGC-1α or endurance signal cascade will be discussed. 
Subsequently, the Akt / mTOR Pathway, which is of greatest interest, will be reviewed in 
detail, as resistance exercise is the primary focus of this study. Next the review of 
literature will examine betaine supplementation, specifically beginning with an overview 
of the biological roles of betaine. Then the review of literature will focus on recent 
studies examining the ergogenic effect of betaine supplementation on human 
performance. Finally, the possible interaction of muscle signaling and betaine 
supplementation will be examined.    
 
Muscle Signaling 
Muscle Signaling Overview 
 Skeletal muscle adaptations to exercise are specific to the modality of the training 
37
. The mechanical signal of exercise activates a specific signaling cascade that result in a 
transient change in gene transcription, which over frequent bouts of exercise will result in 
increased protein synthesis 
8
. The increase in protein synthesis is specific to the exercises 
performed and to the motor units recruited. On the two ends of the spectrum, resistance 
training and endurance training, result in different mechanical signals in the muscle, and 
resultant different molecular activation and overall protein synthesis 
9
. Resistance 
exercise, characterized by short duration high intensity contraction, promotes protein 
accretion, muscle hypertrophy and strength gains, while endurance training, characterized 
 5 
 
by longer duration low intensity contractions, promotes increased mitochondrial density 
and resistance to fatigue 
9
. Thus, the form of exercise stimulates a certain signal cascade 
which results in the overall genotypic and phenotypic changes associated with the given 
training.  
 The key regulatory and rate-limiting step in protein synthesis is the initiation of 
messenger RNA (mRNA) translation 
4
. The initiation of protein translation begins with 
the assembly of the preinitiation complex at the AUG start site on the 5-end of the 
mRNA.  The formation of the preinitiation complex and thus the beginning of protein 
translation depends on the binding of initiator methionyl-tRNA to the 40S ribosomal 
subunit to form the 43S preinitiation complex, which then binds to the mRNA to form the 
48S preinitiation complex. These translation initiation steps are regulated by specific 
signal cascades 
4
. Thus, translation initiation and, therefore, protein synthesis is regulated 
by the signal cascade produced by the given activity performed.  
 As previously stated, endurance training represents one end of the physical 
activity spectrum, where altered gene expression results in the muscle phenotype with 
improved resistance to fatigue 
8
. Resistance to fatigue and oxidative capacity is mainly 
determined by the mitochondria. Indeed, endurance training results in increased 
mitochondrial density and enzyme activity, together termed „mitochondrial biogenesis‟ 
due to a signal cascade that results in the increase in mitochondrial transcription factors, 
specifically through the AMPK / PGC-1α signaling pathway 8. On the contrary, 
resistance training adaptations include increased muscle cross-sectional area and neural 
recruitment. The increase in muscle hypertrophy is regulated by the increase in 
transcription factors for protein synthesis, specifically induced by the phosphorylation of 
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the protein kinase B (Akt) / mammalian target of rapamycin (mTOR) signaling pathway 
8, 56
. Interestingly, these two pathways are inversely related, where an increase in the 
AMPK / PGC-1α activity causes a decrease in the Akt / mTOR pathway activity and vice 
versa 
9
. Thus, diverse contractile activity (i.e. mixed or concurrent training) may not be 
optimal for endurance or resistance specific training adaptations (Figure 2.1, Hawley et 
al. 
20
). 
 
 
Figure 2.1: Intracellular signaling networks mediating exercise-induced skeletal muscle 
responses to resistance- and endurance-based exercise training programs. Resistance-
based exercise induces an increase in the activity of the PI-3K/Akt/mTOR signaling 
cascade to regulate protein synthesis and degradation, which over a prolonged period 
results in muscle hypertrophy. Endurance-based exercise activates signaling pathways 
involved in metabolic homeostasis, comprising of AMPK / p38 mitogen-activated protein 
kinase (MAPK) / PGC-1α axis. Activation of AMPK by endurance exercise inhibits 
mTOR signaling via tuberous sclerosis complex (TSC) and suppresses resistance-
exercise-induced muscle-protein synthesis. 4EBP1 – eukaryotic initiation factor 4E-
binding protein 1; CaMK – calmodulin-dependent protein kinase; EIF4E – eukaryotic 
translation initiation factor-binding protein; p70 S6k –70 kDa ribosomal protein S6 
kinase; TSC1/2 – tuberous sclerosis complex 1 and 2. 20 
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AMPK / PGC-1α Pathway 
 It is well known that muscle contraction from exercise results in an energetic 
challenge to the muscle. As adenosine triphosphate (ATP) is used for energy, adenosine 
monophosphate (AMP) increases. AMPK is considered an energy sensor of the cell. It 
consists of a catalytic subunit (AMPKα) and two regulatory subunits (AMPKβ and 
AMPKγ) 28. AMPKγ binds two AMP molecules cooperatively and has a high sensitivity 
to small changes in AMP concentration. Furthermore, ATP binds to AMPKα to 
allosterically regulate and inactivate the enzyme 
28
. Therefore, AMPK not only responds 
to AMP, but also the ATP to AMP ratio. The binding of AMP to AMPK alters the 
conformation to allow for upstream protein kinases, specifically the tumor suppressor 
LKB1 
28, to phosphorylate the α subunit on threonine 172 in order to activate it 24.  
 When activated, AMPK has regulatory effects on glucose uptake, fatty acid 
oxidation, glycogen metabolism, and protein synthesis. Overall, AMPK inhibits energy 
consuming pathways (i.e. protein synthesis) and activates pathways to release energy (i.e. 
carbohydrate and fatty acid catabolism) 
20
. AMPK has been shown to increase the 
glucose transporter GLUT4 on the muscle plasma membrane to increase glucose uptake 
24
, and promote fatty acid oxidation by inhibition of acetyl-CoA carboxylase and 
activation of malonyl-CoA to increase glucose availability 
20
. Furthermore some studies, 
though still tentative, have shown that AMPK activates hormone sensitive lipase (HSL), 
which is thought of as the rate limiting enzyme in intramuscular triglyceride (IMTG) 
breakdown, to further liberate energy 
24
. As an energy conserving kinase, AMPK also 
acts to reduce protein synthesis. AMPK does this by down regulation of the mTOR 
pathway. It is thought that AMPK phosphorylates tuberous sclerosis complex 2 (TSC2) at 
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threonine 1227 and serine 1345, which improves its ability to inhibit mTOR activity, as 
well as by directly phosphorylating mTOR at threonine 2446, which prevents Akt 
phosphorylation of mTOR at serine 2446 and further signaling 
34
. As expected, many 
studies 
24, 28, 34
 show that treatment with aminoimidazole carboxamide ribonucleotide 
(AICAR), an AMPK activator, results in decreased protein synthesis, as well as down 
regulation of Akt, mTOR, and downstream targets, p70 S6k1 and 4E-BP1.  
 Beyond immediate cellular homeostasis responses, AMPK directly 
phosphorylates PGC-1α, which controls transcriptional factors for mitochondrial 
biogenesis 
33, 54
.  By maintaining cellular homeostasis via liberating energy and inhibiting 
energy consuming processes, as well as increasing mitchondrial biogenesis the AMPK / 
PGC-1α pathway results in the endurance training phenotype one would expect.  
 
Akt  / mTOR Pathway 
 The Akt / mTOR pathway is the primary focus of this study, as we are specifically 
looking at strength and power gains. To appreciate the entire picture of Akt / mTOR 
anabolic signaling (Figure 2.2, adapted from Spiering et al. 
45
) one must consider the 
many interactions during resistance exercise. 
 As previously stated, resistance exercise promotes muscle hypertrophy and 
strength gains in part through the Akt / mTOR signaling cascade that culminates with the 
increased mRNA translation initiation and overall increase in protein synthesis. To begin, 
mechanical deformation of skeletal muscle (i.e. resistance exercise) activates calcineurin, 
mitogen activated protein kinase (MAPK) and insulin-like growth factor signal cascades 
specific to the mechanical stimuli (i.e. frequency and intensity) 
8
. Also, neural activation 
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and the release of calcium from the sarcoplasmic reticulum is specific to the contractile 
activity 
8
. In fact, the muscle contraction itself stimulates mTOR directly through 
phosphatidic acid production 
45
. Thus, the muscle actions during resistance exercise 
directly (through mechanical deformation) and indirectly (through the hormonal 
responses) stimulate signal cascades and muscle growth 
46
.  
 
 
Figure 2.2: The many effects of resistance exercise on Akt / mTOR signaling pathway. 
The contractions from resistance exercise not only have their own actions (i.e. stimulating 
AMPK and Akt), but also incite hormonal responses, specifically, the increase in cortisol, 
insulin-like growth factor -1 (IGF-1), growth hormone (GH). Furthermore, the slight 
increase blood glucose as the need for energy increases causes an increase in insulin. The 
overall balance of this signaling cascade results in the adaptations made. (Adapted from 
Spiering et al. 
45
) 
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Muscle fiber actions, as well as hormonal responses through PI-3K 
phosphorylation, phosphorylate Akt 
56
. Akt signaling is important as it is a central factor 
and contributes to downstream phosphorylation of targets. When Akt is phosphorylated 
(either by PI-3K or mechanical stimuli) at serine 473 (Akt S473), it is then able to 
phosphorylate mTOR. Specifically, Akt S473 phosphorylates and activates mTOR on the 
serine 2448 residue (mTOR S2448), which increases mTOR activity and favors mTOR to 
subsequently phosphorylate p70 S6k and hyperphosphorylate 4E-BP1. mTOR S2448 
phosphorylates p70 S6k on the threonine 389 residue (p70 S6k T389) and activates it. 
p70 S6k T389 then can phosphorylate the S6 subunit of the 40S ribosomal protein, which 
hypersphosphorylates the ribosomal protein S6 and then increases translation of mRNAs 
encoding translational factors. 4E-BP1 normally inhibits eukaryotic translation initiation 
factor 4E (eIF4E) by binding to it, but when mTOR S2448 hyperphosphorylates 4E-BP1 
it releases from eIF4E. By releasing eIF4E from 4E-BP1 it is able to form the translation 
initiation complex eukaryotic translation initiation factor 4F (eIF4F) and bind to the cap 
structure of the mRNA and promote translation initiation. 
4, 45
 
 Hormonal responses to resistance exercise are well documented 
29, 45, 46
. Although 
they depend partly on the acute program variables (exercise choice, exercise order, load, 
volume, and rest intervals) of the exercise protocol, the responses are generally similar 
46
. 
Human GH (22 kD) acutely increases during and following resistance exercise of 
sufficient volume and intensity. The magnitude of this increase seems to be related to the 
total work performed where moderate to high intensity exercise, high in volume with 
relatively shorter rest intervals, results in the highest GH responses
29
.When GH binds to 
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its membrane receptor, it activates janus kinase 2 (JAK2) signaling which then signals to 
PI-3K to continue to promote the anabolic signal 
46
. Similarly, acute resistance exercise 
causes an increase in IGF-1 post exercise, as well as alters IGF binding proteins and 
existing IGF-1 biological activity 
46
. Furthermore, IGF-1 binds to the receptor and 
induces the phosphorylation of insulin receptor substrate (IRS). IRS then activates PI-3K 
which phosphorylates Akt and continues the signal as described above 
34
.  
 Insulin is a potent anabolic signal and has significant positive effects on protein 
synthesis when amino acids are available. Hence, ingestion of carbohydrate and/or amino 
acids pre, peri, or post workout is recommended to utilize this potent anabolic signal 
29
. 
Analogous to IGF-1, insulin binds to the IRS receptor and activates PI-3K and Akt 
signaling 
8
.   
 On the contrary to the anabolic signals of GH, IGF-1 and insulin, cortisol is a 
catabolic glucocorticoid and has an inhibitory effect on protein synthesis. Acute 
resistance exercise can impose a major stress to the body and, accordingly, stimulates 
cortisol release. Similar to GH, cortisol release seems to be highest during high volume, 
moderate to high intensity workouts with short rest periods 
29
. Also, it has now been 
showed that glucocorticoids have a direct inhibitory effect on the Akt signaling pathway, 
specifically on p70 S6k and 4E-BP1 phosphorylation 
43, 44
. Ultimately, cortisol may 
reduce the efficiency of p70 S6k T389 phosphorylation via conformation autoinhibition 
42
. Also, 4E-BP1 is dephosphorylated by glucocorticoids causing it to remain bound to 
the eIF4E
43
. The inhibitory stimulus is more powerful in p70 S6k and cannot be 
recovered with IGF-1, where 4E-BP1 inhibition is reversed 
44
.  
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 Overall, Figure 2.2 summarizes the interaction of the Akt / mTOR signaling 
pathway and resistance training mechanical and hormonal responses. It is important to 
note the strong inhibitory effect of cortisol and AMPK on protein synthesis, as both are 
normal responses to resistance training. Thusly, this results in a balancing between the 
stimulatory effects and inhibitory effects. 
Akt / mTOR signaling is a constantly evolving field of inquiry, where interactions 
and effects from supplementations are yet to be evaluated. Recent research has focused 
on nutritional interactions, as well as concurrent workout effects. Since the Akt / mTOR 
pathway plays an integral role in protein synthesis and overall training adaptations, 
further research regarding these interactions is warranted.  
 
Betaine Supplementation 
Betaine Overview 
 Originally isolated in the 1860‟s by German chemist Carl Scheibler from sugar 
beets (Beta vulgaris) 
32
, Betaine has been known by other names, including 
trimethylglycine, glycine betaine, lycine, and oxyneurine 
11
. It is a neutral zwitterionic 
compound 
32
 and a methyl derivative of glycine 
11
. Along with sugar beets, many other 
foods, such as wheat bran, wheat germ, spinach, pretzels, and shrimp, have high betaine 
content, although their levels vary highly with different sources (i.e. environmental 
conditions during growth) and cooking methods 
11
. Another way humans obtain betaine 
is from dietary choline, as the liver and kidney can oxidize choline to betaine in a two-
step enzyme-dependent reaction 
11, 49
.  Though study results vary slightly, it is estimated 
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that the average daily intake of betaine is between 100 – 300 mg 32, 49, but some studies 
have shown that dietary intakes of 9 – 15 g per day is still safe 11.  
 Once ingested, betaine is rapidly absorbed in the duodenum of the small intestine. 
Peak serum concentrations of betaine are seen approximately 1 – 2 hours postprandial 11. 
Betaine is known to have two major roles in the body: a methyl group donor and an 
organic osmolyte. When betaine is catabolized, which primarily occurs in the 
mitochondria of the liver and kidney, a series of transmethylation reactions occur; most 
significantly a methyl group is transferred from betaine to homocysteine 
11
. 
Homocysteine is methylated and converted to methionine, while betaine becomes 
dimethylglycine 
11
. This reaction is catalyzed by betaine-homocysteine methyltransferase 
(BHMT) 
11, 32
.  By remethylating homocysteine to methionine, betaine conserves 
methionine, detoxifies homocysteine, and produces S-Adenosylmethionine (SAM) 
11
. 
SAM is used in many other biological reactions as a direct methyl donor, specifically it 
participates in the pathways of protein, creatine, phospholipid, and carnitine synthesis, as 
well as DNA methylation
11
. 
 When betaine is not catabolized, it is an organic osmolyte that can regulate cell 
volume 
11, 49
. Interestingly, BHMT is osmoregulated to divide the two separate roles of 
betaine 
49. Along with cell volume regulation, betaine is a “compensatory” solute that 
stabilizes proteins and is especially effective in countering the denaturing effect of urea 
49
. In particular, betaine protects muscle myosin ATPases and prevents urea build up in 
muscle 
11
 that may lead to inhibition of protein synthesis. Furthermore, Brigotti et al. 
showed the addition of betaine actually increased translation of globin mRNA by rabbit 
reticulocyte lysates 
5
, supporting the hypothesis that betaine is essential to maintain 
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osmolarity and facilitate a hospitable environment for protein synthesis and perhaps other 
necessary physiological functions.  
 Betaine has also been linked to a variety of other positive actions. It is a lipotrope 
that has been shown to prevent and reduce fat accumulation in the liver in both animal 
and human studies 
11
. Betaine even shows antiatherosclerotic actions 
11
, reduces aortic 
inflammatory responses 
49
, and decreases fatty acid synthesis and tissue lipids in animal 
studies 
32
. Furthermore, low betaine plasma levels and high urinary betaine loss is 
correlated with elevated plasma lipids and other components of the metabolic syndrome, 
while markers of obesity (BMI, percent body fat and waist circumference) have a 
negative association with betaine plasma concentrations 
32
.  
 Betaine is commonly included in animal feed, as it has shown to increase muscle 
mass, and decrease fat mass in many studies 
32
. Eklund et al. 
15
 speculated the carcass 
composition change could be due to a methionine sparing effect allowing more efficient 
use of dietary protein, though explanations vary among studies. Betaine has been shown 
to increase muscle mass, decrease fat mass or both in poultry 
57
 and pigs 
36
 in many 
different studies 
15
. Furthermore, betaine supplementation in untrained horses caused 
decreased levels of lactate accumulation post exercise 
52
. These beneficial effects seen in 
animals combined with the many essential roles of betaine demonstrated in humans, 
specifically as an osmolyte and a methyl donor for creatine synthesis in skeletal muscle, 
support the contention that betaine supplementation might enhance performance in 
humans.  
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Betaine and Human Performance 
  Although the studies on betaine supplementation and human performance are 
limited, they show the need for more research, as results seem promising. As suggested 
by Craig 
11
 and Lever and Slow 
32
, betaine supplementation may reduce fatigue and 
improve athletic performance via its role as an osmolyte and a methyl donor to produce 
creatine de novo. Furthermore, Craig et al. 
12
 showed that the mean betaine content of 
sweat in adolescent girls was 232 ± 84 μmol/L, which is seven times greater than betaine 
content of typical female plasma. Though this study is the only study that shows the 
betaine content of sweat, it further supports that during strenuous exercise when sweating 
is elevated, betaine supplementation may be beneficial to replace the betaine loss in 
sweat. 
 Armstrong et al. investigated the influence of betaine supplementation on 
strenuous running and sprinting 
1
. This study focused on betaine as an organic osmolyte 
investigating its effect on cardiovascular function and thermal homeostasis during 
rehydration, specifically looking at its potential ergogenic effects with endurance 
performance. Well-trained competitive runners first dehydrated to -2.7% body mass, then 
consumed 1 L of rehydration fluid (with or without betaine (5g/L) in water or a sports 
drink containing carbohydrates and electrolytes) before they began the running 
performance trial. The running trial performance consisted of 75 min at 65% VO2 max 
followed by a timed sprint to volitional exhaustion at 84% VO2 max.  Results showed a 
nonsignificant trend of increased sprint duration with betaine supplementation (16% and 
21% increase with betaine and water or sports drink, respectively). These trends 
corresponded with thermal sensation ratings of the subjects throughout the protocol. 
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Interestingly, plasma lactate during the betaine and sports drink trial was greater than 
during the sports drink alone immediately and 15 minutes after completion of the 
workout, but due to the complexities of lactate turnover, little could be said whether this 
effect was due to enhanced clearance of lactate from the muscle, enhanced muscle 
glycolysis, or another unknown mechanism. Betaine supplementation increased energy 
production via aerobic metabolism, as seen by increased oxygen consumption during the 
betaine and sports drink trial compared to the sports drink alone. In addition, during 
recovery the loss of water from plasma was greater during the betaine and water 
rehydration fluid than with water alone, but no difference was seen in the sports drink 
trials. This phenomenon was explained by increased transport of betaine across the 
muscle membrane creating an osmotic gradient, and the sports drink osmolality was great 
enough to create entirely different gradients. 
1
 
The Armstrong et al. study showed some promise in betaine supplementation, but 
the study also pointed out some flaws that made it harder to interpret the results. First, the 
standard deviations of the sprint time were large making it hard to find a significant 
difference among trials. They hypothesized that a more homogenous sample may have 
made the findings significant. Second, betaine supplementation was only ingested once 
45 minutes before the exercise trial, but not entirely before exercise (i.e. after the 
dehydration protocol). Studies have shown that betaine peaks approximately 1 -2 hours in 
the serum following supplementation 
11
. Also, since dehydration already took place 
before supplementation, the protective effect of betaine as an osmolyte may have been 
harder to observe. Furthermore, a single acute supplementation may not be enough to 
induce ergogenic effects, similar to creatine supplementation, as betaine is also an 
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intracellular component 
1
. Overall, Armstrong et al. was able to show that betaine 
supplementation altered metabolism, but its definitive benefits and mechanisms, and to 
what activities it might be best suited for, were not determined. 
As choline is a precursor to betaine, it is also of interest to look at the effect of 
choline supplementation on endurance performance. Despite some studies showing 
decreases in plasma choline during strenuous prolonged exercise 
26
, choline 
supplementation did not increase cognitive or physical performance in most cases 
39
, and 
furthermore overall did not seem to increase endurance performance 
26, 39, 51
. It is 
important to note that choline is not solely oxidized to betaine in the body, it is also 
acetylated in cholinergic neurons to acetylcholine (a neurotransmitter) and is utilized in 
other physiological pathways 
49
. Because of these alternate pathways, choline 
supplementation is not hypothesized to be directly the same as betaine supplementation, 
but since more research has been done on choline supplementation and endurance 
training, it is still of interest to mention. 
Betaine supplementation is hypothesized to increase creatine synthesis. This 
suggests that betaine supplementation may have more of an applicability to power and 
resistance exercise. The two studies that investigated the effect of betaine 
supplementation on power and strength had similar results with some minor differences.  
Hoffman et al. 
21
 utilized a double-blinded, between group design where 24 
recreationally active men were matched and randomly assigned to either a betaine or 
placebo group. The subjects were tested for two consecutive days at baseline (prior to any 
supplementation), then began consuming the betaine supplement (1.25 g of betaine twice 
daily) or placebo, and then were tested again on day 7 and day 14 of supplementation for 
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muscular endurance, strength, and power. Specifically subjects performed vertical jumps, 
bench throws, and as many repetitions as possible at 75% 1 RM for bench press and back 
squats on day 1 of testing and Wingate anaerobic tests on the following day. Hoffman et 
al. 
21
 showed no difference in the bench throws, bench press, vertical jumps, or anaerobic 
power tests. Contrarily, subjects with betaine supplementation performed significantly 
more squat repetitions until exhaustion on day 7 and nonsignificantly, but trending 
towards (p = 0.06) more squat repetitions on day 14. Furthermore, subjects with betaine 
supplementation performed more squat repetitions at 90% or more peak power on day 7 
and day 14 and more squat repetitions at 90% or more of mean power on day 14. This 
may support that betaine supplementation would allow athletes to improve the quality of 
their workouts causing increased performance. Hoffman et al. 
21
 suggested that betaine 
supplementation increased creatine and therefore, increased local muscular endurance 
and power. They also attributed the differences seen in the squat and bench press exercise 
due to the widespread use of bench press in recreationally active men workouts and the 
less common utilization of the squat exercise, as well as the possibility of larger muscle 
mass being affected to greater extent. Furthermore, it has been shown that power 
exercises must be performed regularly to see improvement, and since the power exercises 
in the protocol was not a common part of the subjects‟ workouts, improvements may not 
have been seen. 
21
 
Lee et al. 
31
 performed a similar study, but utilized a randomized double-blinded 
within treatment design with 12 recreationally active men that had been resistance trained 
for at least 3 months including the squat exercise. After baseline testing, subjects 
underwent supplementation of betaine (1.25 g of betaine in 300 ml of sports drink) or 
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placebo (300 ml of sports drink alone) twice daily. Subjects were tested on vertical jump, 
isometric squat, squat jumps, back squat at 85% 1 RM, isometric bench press, bench 
throw, and bench press at 85% 1 RM. Subjects were tested on day 0,1, 14, and 15 (the 
same protocol was repeated the following day to measure the effects of betaine on 
recovery). Lee et al. 
31
 showed that betaine supplementation significantly increased the 
following measures on both day 14 and day 15: power output for 2 of the 4 sets of 
vertical jump, increased force production during isometric squat, increased force 
production during isometric bench press, and increased bench throw power. No 
significance was seen in squat jump power or repetitions until exhaustion of back squat or 
bench press at 85% 1 RM. Overall, Lee et al. supported the hypothesis that betaine 
supplementation would enhance force production and power performances and be a 
useful ergogenic aid for some athletes. 
31
  
Although there are some differences seen between the Hoffman et al. 
21
 and Lee 
et al. 
31
 studies, most of these differences can be attributed to the slight changes in subject 
population and protocol. Hoffman et al. did not specify that the subjects have back squats 
in their regular exercise routine, nor did they have the subjects repeat the power exercises 
in their workouts in between testing. These may have caused the lack of significant 
results in the power and squat exercises observed. In contrast, subjects in the Lee et al. 
study were accustomed to the squat exercise and had a standardized exercise protocol in 
between workouts very similar to the protocol to ensure subjects were use to the power 
exercises. Despite these differences, both studies showed improvement in performance 
with betaine supplementation over time, supporting its use as an ergogenic aid.  
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It is important to note that although both studies showed improved performance, 
neither confirmed a definitive mechanism of enhancement. This warrants the need for 
more research regarding betaine as an ergogenic aid for strength and power athletes, 
specifically to determine a mechanism of action.  
 
Muscle Signaling and Betaine Supplementation 
 Although there is no direct research examining the effect of betaine 
supplementation on muscle signaling pathways, current research shows that there could 
potentially be a significant interaction. As previously stated, animal research shows an 
increase in lean muscle deposition when feed is supplemented with betaine 
15
. Building 
on the animal feed studies, some have examined hormones and growth factors as the 
responsible mediators causing the change in carcass characteristics. This is of interest 
because these factors contribute to the mTOR signaling pathway as stated previously.  
 Huang et al. 
40
 supplemented finishing pigs feed with 0.125% betaine for 42 days. 
Similar to other studies, pigs supplemented with betaine showed improved carcass traits 
(increased lean percentage, increased longissimus muscle area, decrease fat percentage, 
decrease backfat thickness). Along with these changes, pigs supplemented with betaine 
had a 45.61% increase in serum GH, 55.5% increase in serum IGF-1, and 42.34% 
increase in serum insulin compared to the control pigs. Also Huang et al. 
40
 observed a 
significant decrease in fatty acid synthase activity and an increase in hormone sensitive 
lipase activity within adipose tissue and an increase in serum free fatty acid in betaine 
supplemented pigs. Moreover, the increase in GH, IGF-1, and insulin would 
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hypothetically be able to stimulate PI-3K and carry the signal further down the Akt / 
mTOR pathway to promote protein synthesis.  
 As GH is pulsatile, Huang et al. 
22
 further looked at GH in the same finishing pigs 
to show that basal GH, mean GH, and GH pulse amplitude was increased with betaine 
supplementation. Also, betaine supplemented pigs had a decrease in serum urea nitrogen 
concentration and an increase in serum total protein level, further supporting the 
hypothesis of increased protein synthetic rates with betaine supplementation. Overall, 
Huang et al. 
22
showed that betaine supplementation increased GH, IGF-1, and insulin to 
potentiate the anabolic signal in these animals. 
 Similarly, Choe et al. 
7
 supplemented laying hens feed with either 0, 300, 600, or 
1200 ppm of betaine for four weeks. Hens supplemented with 600 or 1200 ppm betaine 
had significantly greater serum IGF-1. This correlated with IGF-1 gene expression in the 
liver. Choe et al. 
7
 based the betaine enhancement on original findings of Kasai et al. 
27
 , 
who showed that glycine, a betaine metabolite, induces an increase in blood GH via a 
dose dependent manner (higher glycine dose (up to 12 g) caused a higher release of GH) 
indicating glycine has a pivotal role in hypothalamic pituitary function. Additionally, 
Choe et al. 
7
 showed that betaine supplementation of 600 ppm increased blood IGF-
binding protein -3 (IGFBP-3) and therefore was able to extend the half-life of IGF-1 and 
enhance its action.  
 Furthering this research question, Yan 
55
 explored the effects of betaine 
supplementation on the hypothalamus and pituitary of finishing pigs. Yan showed 
finishing pigs supplemented with betaine had increased deposition of betaine on the 
hypothalamus, but not on the pituitary. This resulted in the increase in GHRH gene 
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transcription and secretion from the hypothalamus. Therefore, one could postulate betaine 
supplementation causes an increase in GHRH, which leads to an increase in GH release 
from the anterior pituitary 
55
. The increase in GH release would cause the increase in 
muscle growth and fat degradation, and the decrease in fat synthesis, which would result 
in the leaner, more muscular finishing pig seen with betaine supplementation. 
 On the catabolic side of hormonal responses, Matthews et al. 
35
 examined the 
cortisol response in pigs receiving betaine supplementation. It is important to note that 
this study was looking at multiple conditions and the supplementation period was not a 
set time, but rather until the pigs reached a certain weight. No significant difference in 
cortisol was observed with 0.25% betaine supplementation. Furthermore, there was a 
significant interaction effect with betaine supplementation and pen space where there was 
a greater gain in weight when pigs were given greater space and supplemented with 
betaine. This may indicate that the pigs need space to move and exercise in order for 
betaine supplementation to increase protein synthesis and overall weight gain.  
 Parker et al. 
38
 also examined betaine supplementation and cortisol, but was 
primarily interested in dehydration of steers during transportation rather than quality of 
carcass. Steers were examined after 24 and 48 hours of transportation. Again, there was 
no significant difference seen in cortisol with betaine supplementation. 
 Although neither of these studies showed differences in cortisol response, the 
methodology was not optimized to look at betaine supplementation alone. Matthews et 
al.
35
 did not have a set period of time of supplementation and Parker et al. 
38
 only 
supplemented at a single time point. Additionally, the raw data presented in both studies 
did show a nonsignificant decrease in cortisol with betaine supplementation. It could be 
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speculated that prolonged betaine supplementation could provide a more pronounced 
difference. 
 Overall, animal studies have shown that betaine supplementation can increase 
GHRH, GH, IGF-1, and insulin in finishing pigs and laying hens. The studies proposed 
that these hormonal changes result in the phenotypic change in these animals (increase in 
lean muscle tissue and decrease in adipose tissue). Mechanistically, the increase in GH, 
IGF-1 and insulin not only can exert their actions directly, but also through muscle 
signaling. Although no research has been done examining betaine supplementation and 
these hormonal changes or potential muscle signaling effects in humans, the animal 
research, as well as human performance results, support this thought.  
 Therefore, the purpose of this study was to examine at the effect of betaine 
supplementation on human performance, hormonal responses, and muscle signaling 
responses in order to more effectively determine a mechanism of ergogenic action. We 
hypothesized that betaine supplementation would increase strength and power 
performance via increased anabolic signaling hormonally, as well as potentiating the 
anabolic signal through the Akt / mTOR pathway.  
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Chapter 3: Methods  
Experimental Approach 
 In order to assess the effects of betaine supplementation we designed a 
randomized, double-blinded crossover study. Subjects performed an acute exercise test 
(AET) protocol before and after two weeks of supplementation with either betaine 
dissolved in a sports drink (Gatorade, fruit punch flavor, Chicago, Illinois) or a placebo 
(Gatorade, fruit punch flavor). Each AET began with 10 maximal vertical jumps without 
pause, followed by a maximal 10 second isometric bench press, then a maximal 10 
second isometric squat, concluding with 10 minutes of box lifting. Subjects were given 2 
– 5 minutes of rest between exercises, depending on the specific exercise. Vertical jumps, 
isometric squat, and isometric bench press were performed on a force plate (Accupower, 
Athletic Republic, Fargo, ND) to determine force and power output. The number of 
boxes lifted during the box lift test was used to evaluate muscular endurance and work 
capacity. During each AET, blood samples were obtained at pre, mid, post, +5, and +15 
and were analyzed for GH, IGF-1 and cortisol. Also during each AET, muscle biopsies 
were obtained from the vastus lateralis at pre and +10 and were analyzed for select 
muscle signaling proteins (Total Akt, Akt S473, p70 S6k1, p70 S6k1 T389, and AMPK 
T172). Following a 14 day washout period, subjects crossed over to the other 
supplementation protocol and performed the same pre and post AETs.  
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Experimental Timeline 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.2: Acute exercise test (AET) protocol. Pre – Baseline; prior to any exercise; 
Mid – Middle of exercise protocol; Post – post exercise protocol; +5, +10, +15 – time 
point (in minutes) based on end of exercise protocol.  
 
  
Figure 3.1: Overall experimental timeline of randomized crossover study design. 
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Subjects 
 Twelve recreationally active college men volunteered to participate in this study 
(Table 1). Subjects had been resistance training with the inclusion of the bench press and 
back squat exercises at least 2-3 times per week for the preceding three months, though 
the subjects averaged over four years of general resistance training. The subjects were 
given verbal and written explanation of the study requirements and associated risks, and 
then signed an informed written consent to participate which was approved by the 
University of Connecticut Institutional Review Board.  
 
 
Table 3.1: Descriptive characteristics of subjects. 
Variable Mean ± Standard Deviation 
Age (yr) 19.67 ± 1.23 
Height (cm) 172.59 ± 5.61 
Weight (kg) 84.27 ± 15.30 
Body Fat (%) 18.71 ± 7.01 
BMI 28.19 ± 4.02 
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Procedures 
Experimental Controls 
 Healthy college-aged male subjects were recruited as subjects. Subjects were 
excluded if they had any previous medical history that may have complicated the study or 
results. Also, subjects were excluded if they reported taking any drugs (recreational drugs 
or prescription drugs that may have an interaction), protein supplements, carbohydrate 
supplements, creatine, or other dietary supplements that may have caused confounding 
results. Subjects that fit within our inclusion criteria were reviewed by the medical 
monitor to ensure their safety and the validity of our results.   
For three days prior to the first AET, subjects recorded their daily food and 
beverage intake and replicated this diet before each additional AET. Also during the three 
days preceding an AET, subjects refrained from alcohol, caffeine, and any exhaustive 
exercise. Subjects maintained a physical activity log throughout the study and replicated 
their physical activity and exercises from the first two week supplementation period 
during the second two week supplementation period. Additionally, subjects performed a 
standardized whole-body resistance workout weekly during the study to ensure that their 
level of conditioning was maintained. Subjects fasted for 12 hours prior to their arrival 
for the scheduled AET with the exception of water. Subjects were instructed to drink an 
extra 0.5 L of water prior to going to bed and when they awoke to ensure that they were 
in a euhydrated state when they arrived in the laboratory. Hydration was measured by 
urine refractometry (Model A300CL, Spartan, Japan). Subjects were considered 
euhydrated if their urine specific gravity (USG) was 1.020 g/ml or below. If subjects 
were not euhydrated, they drank water ad libitum and were evaluated for hydration status 
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in 30 minute increments until they had a USG of 1.020 g/ml or below. Subjects did not 
begin any specimen collection or exercise protocol until they were euhydrated to control 
for any variations due to hydration status. Also, to control diurnal hormonal changes and 
performance variations subjects arrival times were consistent with each subject among 
AETs. 
Prior to the beginning of the AETs, subjects came in for a familiarization visit to 
allow them to become accustomed to the exercise protocol. At this time the subjects‟ 
height was measured via a tape measure to the nearest 0.1 cm and total body weight was 
recorded to the nearest 0.1 kg on a digital scale (OHAUS Corp., Fordham Park, NJ). In 
addition, body composition of the subjects was determined via Dual Energy X-ray 
Absorptiometry (DEXA) (Lunar, Prodigy, GE). Following anthropometric assessments, 
the subjects were taught a standardized light warm-up consisting of 5-minutes on a 
stationary bicycle followed by dynamic stretches, including heel kicks, lunges, high 
knees, high kicks, and bodyweight squats. This warm-up was repeated prior to the 
exercise protocol on each AET day for control purposes. Furthermore, during this visit 
subjects were familiarized with the specific exercises comprising the AET. The vertical 
jumps, isometric squat, and isometric bench were performed on the force plate 
(Accupower) as would be done during the AETs. Subjects were familiarized with proper 
isometric bench press position. Specifically, the bar was placed approximately 6 inches 
above the chest, about 1/3 of the way up with elbows at approximately a 120 angle. The 
bar was locked to the nearest rack position on the Smith Machine (LifeFitness, Schiller 
Park, IL). This position was noted and used for all the following AETs to ensure 
consistency. For the isometric squat exercise, the subject assumed a quarter squat position 
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and the bar was locked to the nearest rack position on the Smith Machine. Again, this 
rack position was noted and used for all the following AETs. For both exercises, subjects 
were given a 3-2-1 count to gradually increase pressure and push to maximal exertion 
over 10 seconds. Subjects were introduced to the box lift test and practiced lifting the box 
correctly and placing it on the platform.   
  
Protocol 
 To begin AET days, as previously stated, subjects arrived at the laboratory at their 
designated time. Their hydration level was measured via urine refractometry (Model 
A300CL, Spartan, Japan). After euhydration was ensured, a trained phlebotomist inserted 
an indwelling Teflon cannula into the antecubital vein and the Pre blood sample was 
obtained. Next, the Pre muscle biopsy was obtained.  
Subjects then performed the standardized warm-up protocol. Next they executed 
ten maximal vertical jumps without pause. Subjects were given time to recover before 
they began the isometric bench press. The rack was locked to the assigned position and 
the subject assumed the isometric bench press position with standard grip width. Subjects 
were told to gradually increase pressure with constant back, gluteal, and foot contact as 
previously instructed during the familiarization visit. Subjects pushed to maximal 
exertion for 10 seconds. Following another rest period, the squat rack was locked to the 
assigned position and subjects assumed the isometric squat position. Subjects pushed to 
maximal exertion for 10 seconds. All the preceding exercises were performed on a force 
platform (Accupower) to measure power (W) and force (N). Immediately following the 
isometric squat, the Mid blood sample was drawn.  
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Following the rest period, subjects began the box lifting test. The box lifting test 
consisted of lifting a 18.14 kg metal box with handles on to a 1.32 m high platform from 
0.914 meters away. Two identical boxes were used and an assistant immediately returned 
each box to the start position using a slide system, which allowed a box to always be 
available for the subject to lift. During this 10 minute period the subjects lifted the box to 
the platform as many times as possible. Immediately after completion of the box lift test, 
the Post blood draw was taken. Five minutes after completion of the protocol the +5 
blood was drawn. Subjects were transported to the biopsy room and at +10 the post-
exercise muscle biopsy was obtained. Finally, the +15 blood was drawn.  Also, verbal 
encouragement was given to achieve maximal output for each exercise. 
 
Blood Draws 
 A trained phlebotomist inserted an indwelling Teflon cannula into an antecubital 
vein of the subject. The cannula was kept patent with 10% heparin/saline solution lock. 
Prior to each blood draw, 3 ml of blood was extracted and discarded to avoid inadvertent 
saline dilution of the blood. During each blood draw, 15 ml of blood was collected into 
appropriate tubes for obtaining plasma and serum. Blood tubes were centrifuged at 3000 
rpm for 15 minutes at 4C and resultant serum and plasma was aliquoted and stored at -
80C for later analyses.  
 
Muscle Biopsies 
 A trained physician performed the percutaneous needle biopsy procedure on the 
subjects‟ vastus lateralis muscle using the technique described by Bergstrom 3 modified 
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with suction to obtain a small (~100g) muscle sample. First, the skin was cleaned with an 
alcohol wipe and disinfected using betadine. Then local anesthetic (8-10 cc of 1% 
Lidocaine) was injected in a cone-like fashion 45 degrees proximal and 45 degrees distal 
to the biopsy site to ensure that the muscle fascia and subcutaneous tissue is anesthetized, 
but the muscle sample to be extracted is not harmed. After sufficient time for the 
anesthetic to exert its effect, a small incision (~1 cm) was made through the skin and the 
muscle fascia using a #11 surgical scalpel. A sterile biopsy needle was introduced to the 
muscle through the incision. Suction was used and the inner cannula was advanced to cut 
the muscle tissue. The needle was removed and the incision was covered with sterile 
gauze and compression was applied to prevent bleeding. The incision was then closed 
with sutures. The muscle sample obtained was cleared of excess blood and connective 
tissue, flash frozen in liquid nitrogen, and immediately stored at -80C for later analyses.   
During each AET, Pre and Post muscle biopsies were taken from the same leg, 
approximately 3 cm apart. Two separate sites were used to avoid immune/inflammatory 
responses confounding with the muscle signaling proteins of interest. For the following 
AET, the opposite leg was used to allow the maximum amount of time for recovery.  
 
Supplement 
 Subjects ingested 1.25 g of betaine (Danisco Inc. Ardsley, NY) dissolved in 300 
ml of a sports drink (Gatorade, fruit punch flavor) or a placebo consisting of 300 ml of 
the same sports (Gatorade, fruit punch flavor) twice a day for two weeks. The sports 
drink (Gatorade, fruit punch flavor) nutritional value is as follows:  69.6 kcal, 0 g fat, 0 g 
protein, and 17.4 g carbohydrate. Following the second AET subjects did not take any 
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supplementation for two weeks as a washout period. Following the washout period, 
subjects crossed over to the other supplement condition (betaine or placebo) and 
completed another two week supplementation period. The study was double blinded, so 
the subjects and primary researchers were unaware of the supplement the subjects 
received. Furthermore, subjects could not identify whether or not they were receiving the 
supplement or placebo, as taste and texture was identical.  
 
Biochemical Analyses 
 Blood biochemical analyses (unpublished observations from the study) for GH, 
IGF-1, and cortisol were performed via enzyme-linked immunosorbent assays (ELISA). 
 Muscle samples were homogenized under cold conditions to inhibit any 
enzymatic processes in lysis buffer [Tissue Protein Extraction Reagent (TPER), 10 μl/ ml 
Protease and Phosphatase Inhibitor, and 10 μl/ml EDTA Solution (Thermo Scientific, 
Rockford, IL), more specifically consisting of Tris (pH 7.4) supplemented with aprotinin, 
bestatin, E-64, leupeptin, sodium fluoride, sodium orthovanadate, sodium pyrophosphate, 
b-glycerophosphate, and 0.5 M EDTA] and centrifuged at 10,000xg for 10 minutes at 
4C. The supernatants were extracted and a small portion (5 μl) was used to determine 
total protein concentration via the Bradford assay method (utilizing Coomassie Plus 
Reagent (Thermo Scientific) and the absorbance at 595 nm) to give the total protein 
concentration of the samples. 
 Once the total protein concentrations were known, the samples were diluted to a 
standard of 3 mg/ml with lysis buffer (as described above) and 5X Laemmli buffer (3% 
w/v Tris Base, 10% (w/v) Sodium Dodecyl Sulfate (SDS), 20% Glycerol, 0.2% (w/v) 
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Bromophenol Blue, 5% (w/v) Beta-Mercaptoethanol). Samples were then loaded (30 μg 
total protein per well) in duplicate on a 4 – 15% Tris-HCl gradient gel (Bio-Rad 
Laboratories, Hercules, CA) with Precision Plus Kaleidoscope Protein Standards (Bio-
Rad Laboratories) in each end well as a molecular weight marker. The gel was then 
subjected to sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) in 
electrophoresis buffer (14.4% (w/v) Glycine, 3.02% (w/v) Tris Base, 1% (w/v) SDS, 1 L 
dH2O) and ran at 200V for approximately one hour to allow total protein separation on 
the gel. Proteins were then transferred electrophoretically [50V for 1.5 hours in transfer 
buffer (14.4% (w/v) Glycine, 3.02% (w/v) Tris Base, 800 ml dH2O, 200 ml Methanol) at 
approximately 4C] to a polyvinylidene fluoride (PVDF) membrane (Bio-Rad 
Laboratories).  
Following the transfer, the PVDF membrane was incubated for one hour at room 
temperature in a blocking solution. The blocking solution was optimized for the protein 
of interest. When the protein of interest was Akt Total, Akt phosphorylated at Serine 473 
(Akt S473), or p70 S6K Total the membranes were blocked in a solution of Tris Buffered 
Saline (TBS) with 0.5% Tween-20 (Sigma-Aldrich, St. Louis, MO) (TBS-T) and 5% 
non-fat dry milk (Bio-Rad Laboratories). When the protein of interest was p70 S6K 
phosphorylated at Threonine 389 (p70 S6K T389) or AMPK phosphorylated at Thr 172 
(AMPK T172), the membrane was blocked in a solution of TBS-T and 5% bovine serum 
albumin (BSA) (Sigma-Aldrich).  
After blocking non-specific sites, the membrane was rinsed in TBS-T with 
agitation 3 times for 5 minutes. The membrane was then incubated overnight at 4C with 
agitation in primary antibodies against Akt Total, Akt S473, p70 S6k Total, p70 S6k 
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T389, or AMPK  T172 (Cell Signaling Technology, Inc., Danvers MA). All the primary 
antibodies were rabbit-sourced, polyclonal, and were diluted 1:1000 in 5% BSA TBS-T 
solution. 
Following the overnight incubation, the membrane was rinsed in TBS-T 5 times 
with agitation for 6 minutes. Membranes were then incubated for one hour at room 
temperature with agitation in the species-specific horseradish peroxidase-conjugated IgG 
secondary antibody (anti-rabbit IgG HRP linked antibody, Bio-Rad Laboratories) diluted 
1:2000 in a 5% BSA TBS-T solution. After another subsequent five rinses in TBS-T with 
agitation, the membrane was briefly incubated in SuperSignal West Pico 
Chemiluminescent Substrate (Thermo Scientific) with slight rocking. The membrane was 
then developed in a dark room with X-ray film (Thermo Scientific) and developing 
chemicals (Kodak, Rochester, NY). The visualized bands were captured and quantified 
for densitometric values using a Kodak Imager (Image Station 4000MM Pro, Kodak).  
 
Statistical Analysis 
 Performance results (unpublished observations from the study) were analyzed 
using a condition x time repeated measures analysis of variance (ANOVA). Hormonal 
results (unpublished observations from the study) were computed for area under the curve 
and then analyzed using a condition x time repeated measures ANOVA. Muscle signaling 
results were analyzed for homogeneity. Since densitometric values are measured in 
arbitrary units, values were log transformed to decrease variation. Data was then analyzed 
using a condition x time repeated measures ANOVA with LSD fisher post-hoc 
comparisons used to determine specific pairwise differences. Significance was set at p ≤ 
0.05 for all results.  
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Chapter 4: Results 
 Performance and hormonal results (unpublished observations from the study) are 
presented in order to see the full picture and comprehensively look at the effect of betaine 
supplementation, as examined in this project. 
Performance Results 
No significant differences were seen with betaine supplementation in the vertical 
jumps. There were also no significant differences in the isometric bench press. In 
contrast, there was a significant increase for the change (post supplementation – pre 
supplementation) in force production (Newtons) in the squat exercise following 2 weeks 
of betaine supplementation compared to the placebo (Figure 4.1). Also, there was a 
significantly greater number of boxes lifted following 2 weeks of betaine 
supplementation compared to the placebo condition (Figure 4.2).  
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Figure 4.1: Change (post – pre supplementation) in force production (N) in 
squat exercise over two weeks of supplementation with betaine or placebo.  
* Denotes significantly different from Placebo.  
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Hormonal Results 
 There was a significantly greater area under the curve (for time points during the 
AET) in GH response (Figure 4.3) and IGF-1 response (Figure 4.4) following two weeks 
of betaine supplementation compared to placebo. There was also a significantly reduced 
area under the curve in cortisol (Figure 4.5) following two weeks of betaine 
supplementation compared to placebo. There was a significant time effect for glucose and 
lactate due to exercise, but these were not significantly different supplement. 
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Figure 4.2: Change (post – pre supplementation) in total boxes lifted during 
the ten minute box lift test over two weeks of supplementation with either 
betaine or placebo. 
* Denotes significantly different from Placebo. 
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Figure 4.3: Significant difference in AUC for GH following 2-weeks of betaine 
supplementation.  
* Denotes significant differences between pre- and post-test for Betaine or Placebo.  
‡Denotes significant difference between Betaine Post-Test and Placebo Post-Test. 
Figure 4.4: Significant difference in AUC for IGF-1 following 2-weeks of betaine 
supplementation.  
* Denotes significant differences between pre- and post-test for Betaine or Placebo.  
‡Denotes significant difference between Betaine Post-Test and Placebo Post-Test. 
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Muscle Signaling Results 
 Akt Total, Akt S473, p70 S6k Total, p70 S6k T389, and AMPK T172 
densitometric values (arbitrary units) values were log transformed and are presented as 
means with standard deviation bars. For all of these proteins there was no significant 
difference in pre-exercise and post-exercise per AET. 
 Akt Total pre-exercise was significantly increased (p = 0.003) after two weeks of 
betaine supplementation, and significantly greater than the Pre Placebo pre-exercise (p = 
0.00) and Post Placebo pre-exercise (p = 0.04) (Figure 4.6 and 4.7).  Akt Total post-
exercise was significantly increased following betaine supplementation (p = 0.017), this 
also seen during placebo supplementation, but to a lesser degree (p = 0.029) (Figure 4.8). 
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Figure 4.5: Significant difference in AUC for cortisol following 2-weeks of betaine 
supplementation.  
* Denotes significant differences between pre- and post-test for Betaine or Placebo.  
‡Denotes significant difference between Betaine Post-Test and Placebo Post-Test. 
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 Akt S473 was significantly lower post-exercise following placebo 
supplementation (p = 0.016), but was maintained during betaine supplementation (Figure 
4.9). 
 p70 S6k Total was not significantly different during any time point of any trials 
(Figure 4.10).  
 p70 S6k T389 was significantly decreased pre-exercise after placebo 
supplementation (p = 0.004) while betaine supplementation maintained p70 S6k T389 
pre-exercise (Figure 4.11). p70 S6k T389 was significantly decreased post-exercise after 
placebo supplementation (p = 0.005) while betaine supplementation maintained p70 S6k 
T389 post-exercise as well (Figure 4.12).  
 AMPK T172 was significantly decreased pre-exercise following betaine 
supplementation (p = 0.001). This was also seen during the placebo supplementation 
phase to a lesser degree (p = 0.031) (Figure 4.13). After two weeks of placebo and 
betaine supplementation both had a significant decrease in post-exercise AMPK T172 
(both p = 0.001) (Figure 4.14).   
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Figure 4.6: Pre-exercise muscle biopsy values of Akt Total. 
* Denotes a significant difference between corresponding pre supplementation value 
(betaine or placebo). 
‡Denotes significant difference between both Pre Placebo and Post Placebo iterations. 
Figure 4.7: Pre-exercise muscle biopsy values of Akt Total for all subjects. 
 41 
 
 
 
 
 
 
 
 
7.6
7.7
7.8
7.9
8
Post-exercise Muscle 
Biopsy
Post-exercise Muscle 
Biopsy
Post-exercise Muscle 
Biopsy
Post-exercise Muscle 
Biopsy
Pre Betaine Post Betaine Pre Placebo Post Placebo
Lo
g 
(I
n
te
n
si
ty
) 
(A
U
)
Akt Total Post-Exercise Muscle Biopsy
*
*
5.6
5.8
6
6.2
6.4
6.6
6.8
7
7.2
7.4
Post-exercise Muscle 
Biopsy
Post-exercise Muscle 
Biopsy
Post-exercise Muscle 
Biopsy
Post-exercise Muscle 
Biopsy
Pre Betaine Post Betaine Pre Placebo Post Placebo
Lo
g 
(I
n
te
n
si
ty
) 
(A
U
)
Akt S473 Post-Exercise Muscle Biopsy
*
Figure 4.8: Post-exercise muscle biopsy values of Akt Total. 
* Denotes a significant difference between corresponding pre supplementation value 
(betaine or placebo). 
 
Figure 4.9: Post-exercise muscle biopsy values of Akt S473. 
* Denotes a significant difference between corresponding pre supplementation value 
(betaine or placebo). 
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Figure 4.10 Pre-exercise and Post-exercise muscle biopsy values of p70 S6k Total. 
Figure 4.11 Pre-exercise values of p70 S6k T389. 
* Denotes a significant difference between corresponding pre supplementation value 
(betaine or placebo). 
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Figure 4.12: Post-exercise values of p70 S6k T389. 
* Denotes a significant difference between corresponding pre supplementation value 
(betaine or placebo). 
 
Figure 4.13 Pre-exercise values of AMPK T172. 
* Denotes a significant difference between corresponding pre supplementation value 
(betaine (p = 0.001) or placebo (p = 0.031)). 
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Figure 4.14: Post-exercise values of AMPK T172. 
* Denotes a significant difference between corresponding pre supplementation value 
(betaine or placebo). 
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Chapter 5: Discussion 
 Previous research shows the importance of betaine within the human body. Most 
animal research 
15
 shows that betaine supplementation results in a leaner and more 
muscular animal. Although the results vary slightly, recent human research by Hoffman 
et al. 
21
 and Lee et al. 
31
 showed increases in muscular endurance, force production, and 
power. Agreeing with the previous research, our results showed significant increases in 
force production (increased isometric squat force) and muscular endurance (increased 
number of boxes lifted during box lift test) following betaine supplementation.  
 Mechanistically, animal studies 
7, 22, 40
 have recently shown that betaine 
supplementation can increase GH, IGF-1, and insulin. Although we did not report insulin 
measures, subjects had increased GH and IGF-1 following betaine supplementation. 
Contrary to other betaine supplementation studies that examined cortisol 
35, 38
, we showed 
a significantly reduced area under the curve for cortisol following 14 days of betaine 
supplementation. These differences in results could be due to the longer supplementation 
period in our study and an exercise-focused methodology. Also, it is important to note 
that our study indicates the exercise-induced increase in circulating cortisol was 
attenuated following betaine supplementation rather than a decrease in resting levels all 
together. Thus, it could be speculated that betaine reduces the production and release of 
cortisol during stressful exercise. Since Yan 
55
 observed an increase in betaine deposition 
in the hypothalamus, one could speculate that the betaine supplementation may have 
caused a decrease in the release of corticotrophin releasing hormone (CRH) from the 
hypothalamus, leading to decreased adrenocorticotropic hormone (ACTH) from the 
anterior pituitary and finally, decreased cortisol from the adrenals.   
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Examining the hormonal data collectively provides a thought provoking picture 
since cortisol has been shown to inhibit GH release, specifically by blunting GH release 
in response to GHRH 
13, 41, 48
. Furthermore, CRH has also been shown to inhibit GH 
release stimulated by GHRH 
2
. Additionally, cortisol may increase somatostatin as 
another point of inhibition to GH 
2
. To our knowledge, no other study has reported both 
cortisol and GH responses to betaine supplementation. It could be suggested that the 
decrease in cortisol during the post betaine supplementation trial would decrease the 
inhibitory effects to allow the increase in GH release that was observed in our study. 
Also, though we did not measure GHRH, one would assume the increase in GH secretion 
originated with the increase in GHRH gene transcription and secretion from increased 
betaine deposition on the hypothalamus as Yan observed 
55
. It could also be speculated 
that the decrease in cortisol decreased somatostatin to allow the overall stimulus to the 
anterior pituitary to be more positive and allow increased GH secretion. 
The changes observed in muscle signaling proteins correspond to the pattern of 
changes in hormonal responses. It cannot be determined whether any of the changes in 
muscle signaling were independent of hormonal changes. Interestingly, in our study there 
were no differences in any proteins within each AET. This finding is not very surprising 
as the study was primarily designed to look at performance measures, specifically force 
production. Because we wanted to study force production, the protocol utilized isometric 
exercises rather than concentric and eccentric action. Evidence shows that maximal 
eccentric actions cause the greatest increase in post-exercise p70 S6k phosphorylation 
rather than concentric or submaximal eccentric action 
16
. Though some animal studies 
show similar RNA responses with concentric, eccentric, and isometric actions when force 
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production is equal 
17
, skeletal muscle can generate greater tension during eccentric 
action resulting in the greater signaling responses 
16
. Furthermore, isometric exercise was 
not able to increase the anabolic signal to atrophied rat muscle 
19
.  Overall, isometric 
exercise may not be a sufficient stimulus to evoke immediate signaling responses post-
exercise. Also, due to the box lift portion, the AET was not solely resistance exercise as 
10 minutes of box lifting would rightly be considered partially oxidative. Therefore, the 
AET could be considered a concurrent workout and immediate post-exercise signaling 
responses may be mixed and harder to observe only 10 minutes into the recovery period. 
 Muscle signaling mechanisms are activated at the onset of contraction and 
continue through the recovery period hours after exercise 
6
. Studies show that Akt and 
p70 S6k phosphorylation peaks between the 30 – 60 minutes post exercise, but seems to 
remain elevated for 2 – 6 hours post exercise 6. Since the post muscle biopsy was only 10 
minutes after exercise was completed and not longer into the recovery period, we may 
not have been able to capture the peak phosphorylation of the proteins. Similarly, AMPK 
phosphorylation is also seen within 30 – 60 minutes. Recent research has shown that pre-
exercise feeding (specifically glucose ingestion 
18
) could attenuate the phosphorylation of 
AMPK T172 post-exercise. Despite the fact that betaine levels peak in the serum 
approximately 90 minutes post ingestion 
11
, which has previously been utilized in betaine 
supplementation study protocols 
21, 31
, our subjects were tested in a fasted state, so the 
results would not be confounded by acute pre-exercise feeding. Therefore, the study 
examined long-term (14 days) supplementation effects and avoided the confounding 
influence of acute consumption. 
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Although there were no significant differences observed within each AET, there 
were significant differences after supplementation. There was significantly more pre-
exercise total Akt following betaine supplementation. Although this indicates more 
potential for translation initiation, due to the multiple isoforms and phosphorylation sites 
of Akt, it is not possible to conclude an increase of anabolic signal. Post-exercise Akt 
Total was increased following betaine supplementation. This post-exercise increase in 
Akt Total was also seen in the placebo group to a lesser degree. This may partially be 
explained by the placebo creating an overall positive energy balance due to increase 
caloric intake over the supplementation period. Overall, the changes in total Akt 
following betaine supplementation indicate a slightly higher potential to continue the 
anabolic signal downstream, but are not conclusive. 
Despite the perhaps non-optimal timing of the post-exercise biopsy to detect Akt 
phosphorylation, there was a significant difference following supplementation between 
groups. While the placebo group had decreased post-exercise Akt S473, the betaine group 
was able to maintain the level of protein phosphorylation following the supplementation 
period. Therefore, it appears that the betaine supplementation allowed a greater stimulus 
to phosphorylate and consequently activate mTOR compared to the placebo group. 
Depending on the exact protocol, some studies have shown that resistance training itself 
decreases Akt S473 phosphorylation 
23
, so it was interesting to find that betaine 
supplementation diminished this decrease over the resistance training period.  
Similarly, phosphorylation of p70 S6k T389 was significantly lower after placebo 
supplementation pre-exercise and post-exercise. These levels were maintained following 
betaine supplementation. p70 S6k T389 levels vary greatly due to training volume 
47
, fed 
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state
53
, type of muscle action 
16
, and cortisol inhibition 
44
. The decreased cortisol levels 
during the post betaine supplementation AET likely decreased the inhibitory effect to 
allow p70 S6k T389 phosphorylation and subsequently translation initiation. During the 
other AETs, the higher levels of cortisol likely inhibited the phosphorylation of p70 S6k 
at T389 to a greater extent. This indicates betaine supplementation was able to maintain 
protein synthesis while the placebo supplementation did not. 
As stated previously, the exercise protocol was partially oxidative, so an AMPK 
response would be expected. Since AMPK is a systemic energy sensor 
25
 it is regulated 
by cellular energy state, as well as overall energy balance. Although the placebo 
(Gatorade) did not contain a large amount of calories, it is still possible that the 17.4 g of 
carbohydrates twice daily for two weeks could have created an overall positive energy 
balance and decreased AMPK activation in the post-supplementation AETs. Pre-exercise 
AMPK phosphorylation was decreased with greater significance in the betaine group, 
indicating betaine was able to decrease pre-exercise AMPK phosphorylation greater than 
placebo alone. Post-exercise AMPK phosphorylation was decreased after both 
supplementation periods indicating that the effect of betaine may not have been powerful 
enough after the stressful exercise stimulus to show a difference between betaine and 
placebo effects, but rather the speculated positive energy balance over the two weeks was 
able to cause a significant difference. Studies have shown that the decrease in muscle 
protein synthesis during resistance exercise is associated with an increase in AMPK 
activity 
14
, so one could infer that the decrease in AMPK during the post supplementation 
trials would contribute to enhanced protein synthesis during these trials.  
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Figure 5.1: Overall effects of betaine supplementation on hormonal responses and the 
muscle signaling pathway. 
 
 
 
Overall, betaine supplementation increased performance, as well as anabolic 
hormones and signaling to an extent. The increase in Akt Total pre and post-exercise, as 
well as the maintenance in Akt S473 post-exercise following betaine supplementation 
indicates a greater ability to signal further downstream. These results correspond to the 
increase in GH and IGF-1 AUC during the betaine supplementation. Although there was 
no change in p70 S6k Total, p70 S6k T389 phosphorylation was maintained during the 
betaine supplementation pre and post-exercise. The decrease in p70 S6k T389 during the 
post placebo supplementation trial is explained partially by the increased cortisol levels 
during this time, where the maintenance during betaine supplementation is explained by 
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the decrease in cortisol levels and therefore decreased inhibition to the muscle signaling 
pathway. Furthermore, the decrease in AMPK phosphorylation observed would decrease 
the inhibitory effect on the mTOR pathway, allowing a more positive anabolic signal. In 
total, these observations (Figure 5.1) suggest maintenance of protein synthesis during a 
concurrent workout, and provide a cellular basis to the ergogenic effect of betaine 
supplementation.  
To conclude, our hypothesis was supported to an extent in each area. First, betaine 
supplementation enhanced strength performance as evident in increased force production 
and increased box lift performance. These performance changes correspond to increased 
anabolic hormone levels (GH and IGF-1) and decreased catabolic hormone levels 
(cortisol) following betaine supplementation. Lastly, the performance and hormonal 
improvements are consistent with the muscle signaling responses, including increased 
pre-exercise Akt Total, maintained Akt S473 and p70 S6k T389 phosphorylation, and 
decreased inhibition from AMPK T172.   
Future research should focus on a purely resistance exercise protocol to look more 
closely at the anabolic signaling effects, as well as obtain a later muscle biopsy sample to 
more effectively examine signaling responses during recovery. Also, it would be 
interesting to study the insulin and 4E-BP1 responses to complete the paradigm 
presented. Additionally, to evaluate the hypothalamic point of action, it would be of 
interest to measure GHRH, CRH and other hormones secreted from the hypothalamus 
that may have an influence on performance. Also, since testosterone is a key regulator of 
protein synthesis and integral for examining the entire anabolic picture, it would be 
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interesting to examine the effect betaine supplementation may have. Finally, no study to 
our knowledge has examined the effect of betaine supplementation in women.  
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Appendix A 
 
 
Consent Form for Participation in a Research Project  
 
 
Principal Investigator: Carl M. Maresh, Ph.D. 
Study Title: Betaine II:  Study of Mechanisms in Skeletal Muscle. 
 
1. Invitation to Participate  
You are invited to participate in this study which will investigate the effects of a 
betaine supplement, mixed in Gatorade, on strength and power performance, 
circulating hormone concentrations, and muscle signaling proteins in response to an 
acute exercise protocol. 
 
2. Purpose 
This study is being conducted to see how betaine affects hormone concentrations 
and the proteins involved in muscle growth in response to  exercise. 
 
3. Description of Procedures 
  
 Study overview: 
Betaine is a commonly found amino acid derivative usually extracted 
commercially from sugar beet molasses.  It is found in a variety of foods.  You 
would need to eat about 7 ounces of broccoli to consume the amount of betaine 
you will be supplementing each day during this study. 
 
You will perform an acute exercise test (AET) protocol before and after 2 weeks 
of supplementation with either betaine dissolved in Gatorade or a placebo 
(Gatorade alone). After a 2 week washout (period of time when you do not take 
the betaine supplement or placebo), you will take the other supplement for 
another 2 week period. Before and after the second 2 week supplementation 
period you will perform an AET.   By the end of the study, you will have taken 
both betaine and the placebo, but you will not know which you are receiving at 
those times.  The AET protocol will consist of vertical jumps, isometric bench 
press, isometric squat, and box lifting. Muscle biopsies will be obtained before 
and 10 minutes after the AET. Blood samples will be collected before, once 
during, and 5 and 15 minutes after the AET. Before, during, and after the AET, 
heart rate and rating of perceived exertion will be measured; blood pressure will 
also be measured before, immediately after and 15 minutes after the AET.       
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Before you can be approved for participation you must complete a medical history 
questionnaire and a physical activity questionnaire to ensure that you meet all the 
inclusion and none of the exclusion criteria.  
 
Inclusion: 
To be considered eligible for this study you must be between the ages of 18-35 
years. In addition, you must have been resistance training (at least 2-3 times per 
week) during the 3 months preceding the study.   
 
Exclusion: 
Your medical history form will be reviewed by our medical monitor (Jeffrey 
Anderson, M.D.).  You will not be allowed to participate in this study if you have 
a pre-existing medical condition which may put you at risk while performing the 
strength-testing exercises or that might influence the outcomes of this study. Such 
conditions include, but may not be limited to, heart conditions or anomalies, 
respiratory conditions, blood pressure problems, kidney disease, musculoskeletal 
problems or previous orthopedic injuries that would limit the range of motion 
about the shoulder, elbow, hip, knee or ankle joint.  Special attention will be given 
to exclude potential volunteers with lower back problems including herniated 
inter-vertebral discs. You cannot participate in this study if you have recently 
taken, currently take, or plan to take any hormonal substances such as 
testosterone, anabolic steroids or growth hormone. You will be screened by a 
registered dietician to ensure that you are not taking any nutritional supplements 
or adhere to atypical diets that may confound the results of this study. In addition, 
we reserve the right to dismiss you from this study at any time, if we believe you 
do not follow the instructions provided for this study.    
 
Procedures: 
This study will require that you come to the University of Connecticut Human 
Performance Laboratory (HPL) located in the basement of the Gampel Pavilion for 
five experimental visits (Visit 1,2,3,4,5) and one short follow-up visit the day after 
Visit 2,3,4,5. The follow up visit is for Dr. Maresh or Dr. Kraemer to inspect the 
biopsy sites to ensure proper healing.  
 
Visit 1 (~1.0 hour) 
On Visit 1, we will measure your height and weight. Then, a technician will measure 
your body composition using dual energy X-ray absortiometry.   
 
To familiarize you with the exercise protocol, you will first perform a light warm-up 
that includes 5-minutes of riding a stationary bicycle followed by moving stretches 
(heel kicks, lunges, high knees, high kicks, and unweighted squats).  Then we will 
instruct and familiarize you with how to perform the following exercises: isometric 
bench press, isometric squat, vertical jumps and box lifting.  We will give you plenty 
of rest throughout to ensure that you are not fatigued.  
 
The box lifting exercise consists of lifting and moving a 40 lb metal box. The 
starting position for the box is on the floor, 3 feet from a 1.32 m high platform. 
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The objective of this exercise is to lift the box onto the platform as many times as 
possible in 10 minutes. Two identical boxes will be used in this experiment and 
an assistant will immediately return each box to the starting position using a slide 
system, thus a box will always be available for you to lift. 
 
Visit 2-5 (Acute Exercise Test Visits) (~1 hour each) 
You will arrive at the HPL after a 12-hour over-night fast (no eating or drinking 
anything except for water).  Your hydration state will be tested by means of a urine 
sample prior to the AET.  You will then lie down on a comfortable hospital bed so 
that we can insert a small flexible tube (i.e. catheter) into an arm vein for blood 
draws.  Then you will be prepared for the first biopsy:  We will use a local anesthetic 
to numb an area of your skin and thigh muscle before obtaining a very small amount 
of muscle (about the size of an unpopped popcorn kernel) via a muscle needle 
biopsy.  This is the first of two muscle biopsies that will be taken during these visits.  
Since there are 4 AET visits, a total of 8 muscle biopsies will be performed. 
 
The muscle biopsy involves taking a small piece of muscle tissue from a single 
incision site in your thigh muscle.  Prior to the incision, the skin is cleaned and 
made sterile.  Then the skin and tissue below are injected with local anesthetic to 
eliminate most of the associated pain.  A small incision about the size of this dash 
"_____" will be made through which a needle about the size of this letter "O" is 
advanced into the muscle.  A piece of the thigh muscle is then removed with the 
needle.  The incision site will be closed with a suture and a light dressing will be 
applied. 
 
After the blood draw and biopsy, you will perform a light warm-up that includes 5-
minutes of riding a stationary cycle followed by moving stretches (heel kicks, 
lunges, high knees, high kicks, and unweighted squats). After the warm-up you 
will complete 10 maximal vertical jumps without a pause between the jumps, a ten 
second maximal isometric bench press, a ten second maximal isometric squat and 10 
minutes of box lifting.  Force output will be measured during the jump exercise and 
the isometric bench and squat, and power will be measured during the jump exercise 
using a force platform. Before exercise, immediately after each exercise, and after 
15 min of recovery your heart rate and rating of perceived exertion will be 
measured.  To measure heart rate a heart rate monitor will be strapped around 
your chest just below the pectoral muscles. You will be asked to rate your 
perceived exertion (how hard you feel you are/were working) on a 0-10 point 
scale. The scale includes descriptors such as “weak” and “very strong”.    
 
Immediately after you finish the exercise protocol, we will transfer you back to 
the bed so that we can obtain another blood draw and muscle biopsy from a 
different incision site as previously described.  Once we have finished the last 
biopsy, the skin is closed with a suture and a light dressing is applied as before.  
During the experimental trial, 2 separate incisions on the same leg will be used to 
obtain the 2 biopsies.  These incisions will be made 3 cm (approximately 1 inch) 
apart.     
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We will provide you with an informational take-home sheet that addresses care of 
the biopsy incision sites and will provide you with extra band-aids and topical 
antibiotic.   
 
Supplementation: 
After the first AET protocol you will ingest the appropriate supplement (1.25 g of 
betaine or placebo dissolved in 300 ml Gatorade) twice a day for 2 weeks after 
which you will perform a second AET protocol. After a 2 week washout period, 
you will crossover to the other supplement (betaine or placebo) and complete 
another 2 week supplementation period surrounded by AET protocols. You will 
not know which supplement you are taking during either supplementation period. 
 
You will be asked to complete a diet record for the 3 days prior to each AET.  
These records will include everything that you eat and drink during this time 
period.  You will be asked to replicate the diet you consume for the 3 days prior to 
the first AET for each subsequent AET. 
 
Additionally, you must refrain from resistance training and / or exhaustive 
exercise, alcohol and caffeine during the 3 day period prior to each AET. 
 
4. Risks and Inconveniences 
 
Resistance Exercise 
The performance of strenuous exercise may place you at risk for injury from over-
exertion and/or accident.  This study was designed to minimize the risk for injury.  
Additionally, we will use screening, selecting, and monitoring procedures that are 
designed to anticipate and exclude the rare individual for whom exercise might be 
harmful.  However, for certain individuals, various underlying diseases may 
escape clinical detection.  Therefore, strenuous exercise may be hazardous or may 
precipitate disability.  Some disorders, such as disease/injury of the brain or lung 
circulation are rare and not readily diagnosed in the absence of symptoms; for 
these a history of tolerance to prior strenuous exercise must suffice.  For other 
conditions, which might be more common, such as heart disease, the striking age-
related incidence and the association of several identifiable risk factors with latent 
disease provides a rationale for a directed screening of certain subject candidates.  
 
Performing lower-body resistance exercises such as the isometric squat and the 
box lifting exercise may cause back pain and, in rare instances, back injury.  
Additional risks associated with the exercises in this study involve the possibility 
of muscle strains or pulls of the involved musculature, delayed muscle soreness 
24 to 48 hours after exercise, muscle spasm, and in extremely rare instances, 
muscle tears. Such risks are very low.  Every effort will be made to make this 
investigation safe for your participation through subject familiarization, 
experienced testing personnel, warm-up and cool-down (i.e., stretching and low 
intensity activity-specific exercise), technique instruction and practice, 
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supervision, screening, monitoring and individualized exercise testing. All of 
these factors, including those previously outlined, should dramatically contribute 
to a reduction, if not an elimination, of any potential risks associated with this 
study. All of the laboratory research assistants are trained in CPR, and we have 
documented emergency procedures. 
 
Blood Draws 
We will take blood samples from a small, flexible tube (catheter) which will be 
inserted in a vein in your arm.  There will be discomfort when the catheter initially 
punctures your skin.  There is a small chance that you might develop a bruise at the 
site of the puncture and/or become dizzy / faint.  Additionally, it is possible that an 
infection might occur; however, this is extremely rare.  Insertion of the catheter will 
be done by a skilled technician using sterile techniques. 
 
During Visits 2-5, we will draw about 1.2 table spoons (18 ml) of blood at each 
blood draw for a total of 6 table spoons (90 ml) per visit and thus about 1½ cups 
(360 ml) of blood for the entire study.  The total is about 2/3 of the amount of blood 
typically taken for a Red Cross blood donation.  As a safety precaution, you should 
avoid donating blood 2 weeks before the start of this study through 2 weeks after the 
end of this study.  
 
Muscle Biopsies 
In order to examine the effects of resistance exercise on muscle production of 
hormones, it will be necessary to perform a muscle biopsy on the thigh muscle of 
your leg.  This area of your leg contains no major neural or vascular structures.  The 
muscle biopsy technique has been employed thousands of times with human 
volunteers.  First, a small portion of your leg will be cleaned using an antiseptic 
(betadine).  Then, the biopsy procedure is accomplished by numbing a small portion 
of skin (size of a nickel) and underlying muscle, making a small incision (1/4 inch), 
and inserting a large needle into the muscle.  The sample taken from the muscle 
amounts to the size of ½ to 1 unpopped popcorn kernel.  This procedure is likely to 
cause pain, and a brief period of pressure sensation is usually experienced.  It is 
possible that you might experience an accumulation of blood in the muscle and/or 
under the skin.  In some cases, stiffness in the muscle may occur following the 
procedure but should dissipate within 48 hours.  Such an accumulation of blood 
usually disappears in 1-2 weeks.  In addition, there is a slight risk of infection 
resulting from the incision, but precautions will be taken to minimize such a 
possibility.  Rarely nerve damage and temporary or permanent loss of sensation may 
occur.  You will check in on the day following the biopsies to report any discomfort 
and insure proper healing of the incision.  Ordinarily, small scars remain after the 
incision site has healed.  In 5-10% of dark-skinned persons, however, the wound 
may heal with a fairly thick and conspicuous scar.  If for some reason you have any 
concern regarding the incision site, you will have a contact number to 
immediately deal with the situation.   
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All biopsies will be done by a trained investigator (Jeff Anderson, M.D.)  
Following the biopsies, the skin will be closed via suture by Dr. Anderson.  You 
must report to the HPL on the day after the biopsy procedures so it can be 
confirmed that the incisions are healing properly.  Additionally, if you have any 
concerns about the incisions on the days following the biopsy, you should contact 
the study investigator so that a follow-up appointment with Dr. Anderson can be 
scheduled. 
 
Body compositon analysis 
Body composition analysis for DEXA may involve some health risk, since any 
radiation exposure, no matter how low, may cause abnormal changes in cells.  
The body continuously repairs these changes, but it is conceivable such exposure 
could cause a cancer.  The total exposure for a whole body scan (0.6 mrem) is 
approximately 1/10 of that during a standard chest x-ray (~6 mrem).  Thus, the 
radiation levels are extremely low and the health risk is minimal. 
 
 Supplementation 
The betaine supplement has no known adverse effects at the dose used in this 
study. The placebo contains non-active substances and carbohydrates to give it the 
same taste and appearance as the supplement compound. 
 
Maintanence Training 
During each of the 14-day periods, you will also complete two standardized 
resistance training workouts, each separated by one week, in order to maintain 
your training status throughout the study. 
 
Various Inconveniences:   
The time requirement of this study is about 5 hours (about 1 hours for Visit 1 and 
1 hour each Visits 2-5).  Additionally, you will be asked to keep a detailed dietary 
record for 3 days, which may add a small amount to the time requirements of the 
study.  You will also be asked to fast over-night (12-hours) on one occation. 
 
5. Benefits: 
By participating in this study you will learn how to perform isometric bench and 
squat exercises, vertical jumps and box lifts with correct technique and learn your 
body composition. We will explain all of your individual data collected from this 
study to you and interpret them along with answering any questions you might 
have in relation to these so that you can gain a maximum amount of educational 
understanding and use of your collected data.  In general, this study will provide 
you a better understanding of how a betaine supplement impacts your hormone 
levels in response to a bout of resistance exercise. 
 
6. Economic Considerations:  
You will receive $1000 if you complete all procedures involved in this study: 
If subject fail to finish the study, payments will be prorated as follows: 
 $10 for completing visit 1 
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 $100 for completing visit 1 and 2 
 $200 for completing visit 1, 2 and 3  
 $400 for completing visit 1, 2, 3 and 4 
 $1000 for completing visits 1, 2, 3, 4 and 5. 
 
7. Confidentiality 
All of the data collected will remain confidential, and you will never be identified 
by name in any reporting of the results.  Furthermore, the results will not be 
shared with any person outside of the investigation without your consent.  The 
results for this study will be kept in locked cabinets under the supervision of Dr. 
Carl Maresh.   
 
You should also know that the UConn Institutional Review Board (IRB) and the 
Office of Research Compliance may inspect study records as part of its auditing 
program, but these reviews will only focus on the researchers and not on your 
responses or involvement. The IRB is a group of people that reviews research 
studies to protect the rights and welfare of participants 
 
8. In Case of Illness or Injury 
In the event you become sick or injured during the course of the research study, 
immediately notify the primary investigator, Dr. Carl M. Maresh (office 860-486-
5322). If you require medical care for such sickness or injury, your care will be 
billed to you or to your insurance company in the same manner as your other 
medical needs are addressed.   
 
If, however, you believe that your illness or injury directly resulted from the 
research procedures of this study, you may be eligible to file a claim with the 
State of Connecticut Office of Claims Commissioner.  For a description of this 
process, contact the Office of Research Compliance at the University of 
Connecticut at 860-486-8802.  
 
9. Voluntary Participation 
You do not have to be in this study if you do not want to participate. If you agree to 
be in the study, but later change your mind, you may drop out at any time. There are 
no penalties or consequences of any kind if you decide that you do not want to 
participate. 
 
10. Do You Have Any Questions? 
Take as long as you like before you make a decision. We will be happy to answer 
any question you have about this study. If you have further questions about this 
project or if you have a research-related problem, you may contact the principle 
investigator (Dr. Carl. M. Maresh, Ph.D., 860-486-5322). If you have any 
questions concerning your rights as a research subject, you may contact the 
University of Connecticut Institutional Review Board (IRB) at 860-486-8802.  
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Authorization: 
I have read this form and decided that _________________________________ will  
(name of subject) 
participate in the project described above.  Its general purposes, the particulars of  
involvement and possible hazards and inconveniences have been explained to my 
satisfaction.  My signature also indicates that I have received a copy of this consent form. 
 
Signature:_________________________________ Date:________________ 
  
  
___________________________________________ ___________________ 
Signature of Primary Investigator Date 
 
                                      or 
 
___________________________________________ ___________________ 
Signature of Person Obtaining Consent Date 
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